Literature DB >> 25696160

Hormone replacement therapy and heart disease: the remains of the oestrogen hypothesis.

A H E M Maas, Y T van der Schouw, D E Grobbee, Y van der Graaf.   

Abstract

BACKGROUND: While observational data for postmenopausal women using hormone replacement therapy (HRT) have shown a protective effect against cardiovascular disease, prospective, randomised trials have demonstrated a harmful effect on the vascular system. DESIGN AND
RESULTS: The effects of HRT on lipids, haemostatic parameters, inflammation, and the vascular wall are described. Reasons for the different results of observational and experimental studies of HRT are postulated. The timing of hormonal supplementation seems crucial. Used chronically, HRT has no harmful effects; however, first-time use of HRT after a recent cardiovascular event results in an early increase in adverse cardiovascular events. In most observational studies, women started HRT for postmenopausal symptoms, whereas in experimental studies women started HRT 10 to 20 years or longer after the menopause.
CONCLUSION: HRT has more effect in maintaining vascular health than in alleviating endothelial dysfunction. HRT is not beneficial but harmful in women at risk of a cardiovascular event. The interval between the menopause and starting HRT plays a crucial role in the effectiveness of HRT on the vascular system.

Entities:  

Keywords:  cardiovascular disease; hormone replacement therapy; prevention

Year:  2003        PMID: 25696160      PMCID: PMC2499933     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  34 in total

Review 1.  The protective effects of estrogen on the cardiovascular system.

Authors:  M E Mendelsohn; R H Karas
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

2.  Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial.

Authors:  P Angerer; S Störk; W Kothny; P Schmitt; C von Schacky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-02       Impact factor: 8.311

3.  Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery.

Authors:  T Mori; J Durand; Y Chen; J A Thompson; S Bakir; S Oparil
Journal:  Am J Cardiol       Date:  2000-05-15       Impact factor: 2.778

4.  Estrogen replacement and brachial artery flow-mediated vasodilation in older women.

Authors:  D M Herrington; M A Espeland; J R Crouse; J Robertson; W A Riley; M A McBurnie; G L Burke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

5.  Hormone replacement therapy, heart disease, and other considerations.

Authors:  E Barrett-Connor; D Grady
Journal:  Annu Rev Public Health       Date:  1998       Impact factor: 21.981

6.  Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.

Authors:  S R Heckbert; N S Weiss; T D Koepsell; R N Lemaitre; N L Smith; D S Siscovick; D Lin; B M Psaty
Journal:  Arch Intern Med       Date:  1997-06-23

7.  Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Authors:  H N Hodis; W J Mack; R A Lobo; D Shoupe; A Sevanian; P R Mahrer; R H Selzer; C R Liu Cr; C H Liu Ch; S P Azen
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

8.  Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women.

Authors:  Kwang Kon Koh; William H Schenke; Myron A Waclawiw; Gyorgy Csako; Richard O Cannon
Journal:  Circulation       Date:  2002-04-02       Impact factor: 29.690

Review 9.  Female hormones and thrombosis.

Authors:  F R Rosendaal; F M Helmerhorst; J P Vandenbroucke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-02-01       Impact factor: 8.311

10.  Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload.

Authors:  P S Douglas; S E Katz; E O Weinberg; M H Chen; S P Bishop; B H Lorell
Journal:  J Am Coll Cardiol       Date:  1998-10       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.